Evaluation of one year lamivudine and telbivudine therapy on chronic hepatitis b patient: Based on biochemical, virological and fibrosis status in dr. soetomo general hospital

• Main Authors: Ummi Maimunah, Syalini S.A, Iswan Abbas Nusi, Titong Sugihartono, Budi Widodo, Ulfa Kholili, Husin Thamrin, Amie Vidyani, Muhammad Miftahussurur, Poernomo Boedi Setiawan
• Format: Article PeerReviewed
• Language: English; English; English
• Published: UNIPRINT 2019
• Subjects: R Medicine (General); RC Internal medicine
• Online Access: http://repository.unair.ac.id/108628/1/31.%20Evaluation%20of%20one%20year%20lamivudine%20and%20telbivudine%20therapy%20on%20chronic%20hepatitis%20b%20patient%20Based%20on%20biochemical%2C%20virological%20and.pdf; http://repository.unair.ac.id/108628/2/31.%20Evaluation%20of%20one%20year%20lamivudine%20and%20telbivudine%20therapy%20on%20chronic%20hepatitis%20b%20patient%20Based%20on%20biochemical%2C%20virological%20a.pdf; http://repository.unair.ac.id/108628/3/31.%20Evaluation%20of%20one%20year%20lamivudine%20and%20telbivudine%20therapy%20on%20chronic%20hepatitis%20b%20patient%20Based%20on%20biochemical%2C%20virological%20and.pdf; http://repository.unair.ac.id/108628/; https://ysmu.am/en/journal/vol_13_no_4_2019/
• Institution: Universitas Airlangga

Background: Lamivudine and telbivudine are still the recommended treatment for hepatitis B, especially in Indonesia. However, no conclusive results on evaluation of the lamivudine and telbivudine therapy in Dr. Soetomo hospital in one-year therapy. Objective: To evaluate one-year Lamivudine and Telb...